Date | Time | Source | Headline | Symbol | Company |
04/23/2024 | 4:05PM | GlobeNewswire Inc. | TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K | NASDAQ:MEDS | TRxADE HEALTH Inc |
03/06/2024 | 8:30AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
03/06/2024 | 8:05AM | GlobeNewswire Inc. | TRxADE Health, Inc. Announces Special Cash Dividend | NASDAQ:MEDS | TRxADE HEALTH Inc |
02/26/2024 | 12:00PM | Edgar (US Regulatory) | Form SEC STAFF ACTION - SEC Staff Action: ORDER | NASDAQ:MEDS | TRxADE HEALTH Inc |
02/16/2024 | 5:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
02/14/2024 | 2:50PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:MEDS | TRxADE HEALTH Inc |
01/17/2024 | 9:07AM | GlobeNewswire Inc. | Trxade health, Inc files its 3Q 10Q | NASDAQ:MEDS | TRxADE HEALTH Inc |
01/17/2024 | 9:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
01/16/2024 | 4:05PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:MEDS | TRxADE HEALTH Inc |
01/16/2024 | 6:12AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MEDS | TRxADE HEALTH Inc |
01/11/2024 | 5:25PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
11/29/2023 | 6:13PM | GlobeNewswire Inc. | TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q. | NASDAQ:MEDS | TRxADE HEALTH Inc |
11/28/2023 | 12:29PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
11/15/2023 | 1:51PM | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:MEDS | TRxADE HEALTH Inc |
10/17/2023 | 8:05AM | GlobeNewswire Inc. | TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023. | NASDAQ:MEDS | TRxADE HEALTH Inc |
10/13/2023 | 1:25PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
10/12/2023 | 8:05AM | GlobeNewswire Inc. | Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales | NASDAQ:MEDS | TRxADE HEALTH Inc |
10/11/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
10/04/2023 | 9:29AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
10/04/2023 | 8:05AM | GlobeNewswire Inc. | Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry. | NASDAQ:MEDS | TRxADE HEALTH Inc |
09/25/2023 | 8:06AM | Edgar (US Regulatory) | Form PRER14A - Preliminary Proxy Soliciting materials | NASDAQ:MEDS | TRxADE HEALTH Inc |
09/14/2023 | 5:28PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
09/08/2023 | 10:42AM | Edgar (US Regulatory) | Form PRER14A - Preliminary Proxy Soliciting materials | NASDAQ:MEDS | TRxADE HEALTH Inc |
09/07/2023 | 8:05AM | GlobeNewswire Inc. | Superlatus Announces Planned Expansion into Pet Food Market | NASDAQ:MEDS | TRxADE HEALTH Inc |
08/25/2023 | 6:15AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
08/24/2023 | 9:47AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MEDS | TRxADE HEALTH Inc |
08/24/2023 | 8:05AM | GlobeNewswire Inc. | Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand | NASDAQ:MEDS | TRxADE HEALTH Inc |
08/22/2023 | 8:05AM | GlobeNewswire Inc. | Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc. | NASDAQ:MEDS | TRxADE HEALTH Inc |
08/18/2023 | 4:05PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:MEDS | TRxADE HEALTH Inc |
08/14/2023 | 10:25AM | GlobeNewswire Inc. | TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing | NASDAQ:MEDS | TRxADE HEALTH Inc |